Shelly Karuna

Dr. Karuna has worked at the intersection of science, medicine, and global public health for two decades. Before joining GreenLight, she held several senior positions leading global clinical development of vaccines and monoclonal antibodies for HIV and Covid-19 prevention, treatment, and cure at the NIH-funded HIV Vaccine Trials and Covid-19 Prevention Networks, while practicing as a physician for underserved patients in Seattle. Shelly authors and reviews manuscripts on a wide range of scientific and medical topics for several high-impact scientific journals and she is a Principal Investigator at the Fred Hutch Cancer Center and a scientific advisor to organizations advancing global vaccine equity, HIV prevention, and immunology research. Shelly joined GreenLight to lead clinical strategy to advance RNA-based vaccines and therapeutics as equitable global health solutions, with a particular focus on the priorities of and access by communities in the global South. She is a graduate of Duke University and earned her MD from the University of California, San Diego and her MPH from the University of Washington in Seattle.